11 November 2013 in Journal of Chemical Information and Modeling
18 December 2014 in Blood
Key Points: The hyperactive phenotype of lymphoma-associated mutations is caused by increased oligomerization propensity of the MyD88 TIR domain. The TIR domain of mutants interacts with wild-type MyD88, explaining why heterozygous mutation could be sufficient as a driver mutation.
16 August 2022 in Neurology
ASAshwin Ashok Kumar Sreelatha
Ashwin Ashok Kumar Sreelatha
ECEnvironment in Parkinson's Disease (COURAGE-PD) Consortium
Environment in Parkinson's Disease (COURAGE-PD) Consortium
+79
Background and Objectives Considerable heterogeneity exists in the literature concerning genetic determinants of the age at onset (AAO) of Parkinson disease (PD), which could be attributed to a lack of well-powered replication cohorts. The previous largest genome-wide association studies (GWAS) identified SNCA and TMEM175 loci on chromosome (Chr) 4 with a significant influence on the AAO of PD; these have not been independently replicated. This study aims to conduct a meta-analysis of GWAS of PD AAO and validate previously observed findings in worldwide populations. Methods A meta-analysis was performed on PD AAO GWAS of 30 populations of predominantly European ancestry from the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson9s Disease (COURAGE-PD) Consortium. This was followed by combining our study with the largest publicly available European ancestry dataset compiled by the International Parkinson Disease Genomics Consortium (IPDGC). Results The COURAGE-PD Consortium included a cohort of 8,535 patients with PD (91.9%: Europeans and 9.1%: East Asians). The average AAO in the COURAGE-PD dataset was 58.9 years (SD = 11.6), with an underrepresentation of females (40.2%). The heritability estimate for AAO in COURAGE-PD was 0.083 (SE = 0.057). None of the loci reached genome-wide significance (p < 5 × 10−8). Nevertheless, the COURAGE-PD dataset confirmed the role of the previously published TMEM175 variant as a genetic determinant of the AAO of PD with Bonferroni-corrected nominal levels of significance (p < 0.025): (rs34311866: β(SE)COURAGE = 0.477(0.203), pCOURAGE = 0.0185). The subsequent meta-analysis of COURAGE-PD and IPDGC datasets (Ntotal = 25,950) led to the identification of 2 genome-wide significant association signals on Chr 4, including the previously reported SNCA locus (rs983361: β(SE)COURAGE+IPDGC = 0.720(0.122), pCOURAGE+IPDGC = 3.13 × 10−9) and a novel BST1 locus (rs4698412: β(SE)COURAGE+IPDGC = −0.526(0.096), pCOURAGE+IPDGC = 4.41 × 10−8). Discussion Our study further refines the genetic architecture of Chr 4 underlying the AAO of the PD phenotype through the identification of BST1 as a novel AAO PD locus. These findings open a new direction for the development of treatments to delay the onset of PD.
26 July 2011 in Journal of Chemical Theory and Computation
1 February 2011 in Biochimica et Biophysica Acta (BBA) - Biomembranes
18 September 2017 in Proceedings of the National Academy of Sciences
Significance: Polymorphisms in the endolysosomal cation channel TPC2 have been suggested to lead to a shift in human hair color from brown to blond. In two further studies a role for TPC2 in melanosomal pH regulation was postulated. Electrophysiological data on how these polymorphisms affect channel gating and activity are, however, missing. We show here that both polymorphisms lead to a gain of channel function by different mechanisms. In M484L sensitivity to its endogenous ligand PI(3,5)P 2 is strongly increased while in G734E channel inactivation by ATP is reduced. These findings are corroborated by molecular dynamics and ion substitution experiments. Furthermore, >100 blond- and brown/black-haired human individuals were genotyped and fibroblasts isolated from selected donors to confirm key in vitro findings.